Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
March 31, 1999
Nucleomimetic strategy for the inhibition of HIV-1 nucleocapsid protein NCp7 activities
S Druillennec, H Meudal, B P Roques, et al.
Journal of Medicinal Chemistry
|
March 15, 1996
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors
P Coric, S Turcaud, H Meudal, et al.
International Journal of Peptide and Protein Research
|
June 1, 1993
Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides
C Guis, L Bruetschy, H Meudal, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid
B Bellier, S Da Nascimento, H Meudal, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode
B Bellier, M E Million, S DaNascimento, et al.
Journal of Medicinal Chemistry
|
February 13, 1999
Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach
L Martin, F Cornille, S Turcaud, et al.
Journal of Medicinal Chemistry
|
December 16, 1997
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
B Bellier, I McCort-Tranchepain, B Ducos, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities
H Chen, F Noble, A Mothé, et al.
Journal of Medicinal Chemistry
|
June 21, 1996
Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action
M C Fournie-Zaluski, P Coric, V Thery, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme
C David, L Bischoff, H Meudal, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Bioorganic & Medicinal Chemistry Letters
|
March 31, 1999
Nucleomimetic strategy for the inhibition of HIV-1 nucleocapsid protein NCp7 activities
S Druillennec, H Meudal, B P Roques, et al.
Journal of Medicinal Chemistry
|
March 15, 1996
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors
P Coric, S Turcaud, H Meudal, et al.
International Journal of Peptide and Protein Research
|
June 1, 1993
Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides
C Guis, L Bruetschy, H Meudal, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid
B Bellier, S Da Nascimento, H Meudal, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode
B Bellier, M E Million, S DaNascimento, et al.
Journal of Medicinal Chemistry
|
February 13, 1999
Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach
L Martin, F Cornille, S Turcaud, et al.
Journal of Medicinal Chemistry
|
December 16, 1997
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
B Bellier, I McCort-Tranchepain, B Ducos, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities
H Chen, F Noble, A Mothé, et al.
Journal of Medicinal Chemistry
|
June 21, 1996
Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action
M C Fournie-Zaluski, P Coric, V Thery, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme
C David, L Bischoff, H Meudal, et al.
Page
of 1